Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RPX | Ann: Removal from the official list | 13/05/11 | 0 | 1.0K | |||
|
|||||||
RPX | Ann: Implementation of Scheme of Arrangement and | 13/05/11 | 0 | 941 | |||
|
|||||||
RPX | Ann: RP Data Divests Megaw and Hogg National Valu | 09/05/11 | 0 | 808 | |||
|
|||||||
CGF +RPX | Ann: Ceasing to be a substantial holder from CGF | 05/05/11 | 0 | 810 | |||
|
|||||||
RPX | Ann: Suspension from Official Quotation | 02/05/11 | 0 | 830 | |||
|
|||||||
RPX | Ann: Scheme of Arrangement Sealed Court Orders | 29/04/11 | 0 | 724 | |||
|
|||||||
RPX | Ann: Federal Court approves Scheme and Special Di | 28/04/11 | 0 | 712 | |||
|
|||||||
RPX | Ann: Results of Meeting | 21/04/11 | 0 | 683 | |||
|
See All Discussions